BusinessConformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United KingdomBy Nasdaq OMXMar 1, 2018, 1:01 PM UTC
BusinessConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial GuidanceBy Nasdaq OMXFeb 7, 2018, 9:05 PM UTC
BusinessConforMIS Announces Pricing of Public Offering of Common StockBy Nasdaq OMXJan 25, 2018, 1:01 PM UTC
BusinessConforMIS Announces Proposed Public Offering of Common StockBy Nasdaq OMXJan 24, 2018, 9:01 PM UTC
BusinessConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial GuidanceBy Nasdaq OMXJan 8, 2018, 9:15 PM UTC
BusinessConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%By Nasdaq OMXJan 4, 2018, 11:12 PM UTC
